Brief: Oncolytics Biotech Reports 2021 Third Quarter Development Highlights And Financial Results
05/11/2021 12:25
Nov 5 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS 2021 THIRD QUARTER DEVELOPMENT
HIGHLIGHTS AND FINANCIAL RESULTS
* Q3 LOSS PER SHARE C$0.09
Source text for Eikon: ID:nCNWP1D1Na
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer